EP4435430A4 - Kit zum nachweis von sars-cov-2-antigen und nachweisverfahren - Google Patents

Kit zum nachweis von sars-cov-2-antigen und nachweisverfahren

Info

Publication number
EP4435430A4
EP4435430A4 EP22711856.9A EP22711856A EP4435430A4 EP 4435430 A4 EP4435430 A4 EP 4435430A4 EP 22711856 A EP22711856 A EP 22711856A EP 4435430 A4 EP4435430 A4 EP 4435430A4
Authority
EP
European Patent Office
Prior art keywords
detection
cov
sars
antigen
kit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP22711856.9A
Other languages
English (en)
French (fr)
Other versions
EP4435430A1 (de
Inventor
Xiwen Jiang
Wenchuang QI
Shuang Liu
Xiuhua Pan
Songkang Su
Hong Xu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daan Gene Co Ltd
Original Assignee
Daan Gene Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daan Gene Co Ltd filed Critical Daan Gene Co Ltd
Publication of EP4435430A1 publication Critical patent/EP4435430A1/de
Publication of EP4435430A4 publication Critical patent/EP4435430A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54386—Analytical elements
    • G01N33/54387—Immunochromatographic test strips
    • G01N33/54388—Immunochromatographic test strips based on lateral flow
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/165—Coronaviridae, e.g. avian infectious bronchitis virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/10—Detection of antigens from microorganism in sample from host

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP22711856.9A 2021-11-16 2022-01-28 Kit zum nachweis von sars-cov-2-antigen und nachweisverfahren Withdrawn EP4435430A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202111357502.6A CN114088942A (zh) 2021-11-16 2021-11-16 一种检测新型冠状病毒抗原的试剂盒及检测方法
PCT/CN2022/074466 WO2023087550A1 (zh) 2021-11-16 2022-01-28 一种检测新型冠状病毒抗原的试剂盒及检测方法

Publications (2)

Publication Number Publication Date
EP4435430A1 EP4435430A1 (de) 2024-09-25
EP4435430A4 true EP4435430A4 (de) 2025-02-12

Family

ID=80301144

Family Applications (1)

Application Number Title Priority Date Filing Date
EP22711856.9A Withdrawn EP4435430A4 (de) 2021-11-16 2022-01-28 Kit zum nachweis von sars-cov-2-antigen und nachweisverfahren

Country Status (4)

Country Link
US (1) US20230152315A1 (de)
EP (1) EP4435430A4 (de)
CN (1) CN114088942A (de)
WO (1) WO2023087550A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114624220A (zh) * 2022-04-11 2022-06-14 北京倍肯恒业科技发展股份有限公司 基于侧向荧光层析技术的新冠抗原快检装置及方法
CN115436627A (zh) * 2022-10-10 2022-12-06 中山生物工程有限公司 一种胱抑素c荧光免疫层析检测试剂盒及其制备方法
CN116377136B (zh) * 2023-03-14 2023-09-15 广东海洋大学 一种基于AIE材料快速检测新冠Omicron毒株的荧光生物传感器及其应用
CN118425502B (zh) * 2024-07-05 2024-11-05 深圳市博卡生物技术有限公司 一种用于检测胃癌新型标志物sdf4的免疫层析检测卡及其制备方法
CN119199114B (zh) * 2024-11-28 2025-02-28 吉林重明生物科技有限公司 一种用于呼吸道病毒鉴别诊断的即时检测试剂盒

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111398589A (zh) * 2020-02-13 2020-07-10 北京华科泰生物技术股份有限公司 一种快速检测新型冠状病毒n蛋白的免疫层析试剂盒及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998021581A1 (en) * 1996-11-08 1998-05-22 The Regents Of The University Of California Methods and reagents for non-invasive imaging of atherosclerotic plaque
CN105334319B (zh) * 2015-10-21 2017-06-30 黑龙江省乳品工业技术开发中心 一种检测乳中玉米赤霉烯酮的试纸条
CN107102144A (zh) * 2017-03-16 2017-08-29 深圳市梓健生物科技有限公司 快速检测寨卡病毒ns1蛋白的荧光定量免疫层析试纸条及其制作方法
CN110376374A (zh) * 2019-08-07 2019-10-25 厦门市妇幼保健院（厦门市计划生育服务中心） 一种b族链球菌快速血清学分型的检测试剂盒及其制备方法
CN113337271B (zh) * 2020-03-02 2023-09-01 杭州深度生物科技有限公司 包覆金属纳米壳层的荧光编码微球的制备方法
CN111366729B (zh) * 2020-03-26 2023-03-21 深圳市梓健生物科技有限公司 一种新型冠状病毒covid-19抗原荧光检测试剂盒及其制备方法
CN112305221A (zh) * 2020-10-29 2021-02-02 海卫特(广州)医疗科技有限公司 犬细小病毒检测试剂盒及其制备方法
CN113621099B (zh) * 2021-08-25 2023-08-11 上海奥普生物医药股份有限公司 一种荧光微球及其制备方法和应用

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111398589A (zh) * 2020-02-13 2020-07-10 北京华科泰生物技术股份有限公司 一种快速检测新型冠状病毒n蛋白的免疫层析试剂盒及其制备方法和应用

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CHEN RUI ET AL: "Early Detection of SARS-CoV-2 Seroconversion in Humans with Aggregation-Induced Near-Infrared Emission Nanoparticle-Labeled Lateral Flow Immunoassay", ACS NANO, vol. 15, no. 5, 30 April 2021 (2021-04-30), US, pages 8996 - 9004, XP093234794, ISSN: 1936-0851, DOI: 10.1021/acsnano.1c01932 *
GRANT BENJAMIN D. ET AL: "SARS-CoV-2 Coronavirus Nucleocapsid Antigen-Detecting Half-Strip Lateral Flow Assay Toward the Development of Point of Care Tests Using Commercially Available Reagents", ANALYTICAL CHEMISTRY, vol. 92, no. 16, 18 August 2020 (2020-08-18), pages 11305 - 11309, XP055832021, DOI: 10.1021/acs.analchem.0c01975 *
See also references of WO2023087550A1 *

Also Published As

Publication number Publication date
US20230152315A1 (en) 2023-05-18
WO2023087550A1 (zh) 2023-05-25
CN114088942A (zh) 2022-02-25
EP4435430A1 (de) 2024-09-25

Similar Documents

Publication Publication Date Title
EP4119575A4 (de) Epitope und kit zum nachweis von sars-cov-2 und anti-sar
EP4426863A4 (de) Zusammensetzungen und verfahren zum nachweis von ophthalngealkrebs
EP3919907C0 (de) Verfahren zum quantitativen nachweis von einzelmolekülen und nachweisverfahren
EP4089115A4 (de) Anti-tigit-antikörper und verwendungsverfahren
EP3990667C0 (de) Verfahren zum spezifischen und sensitiven nachweis von sars-cov-2
EP3810806C0 (de) Hydroxymethylierungsanalyse von zellfreien nukleinsäureproben zum zuteilen von ursprungsgewebe und verwandten verwendungsverfahren
EP4083232A4 (de) Kombination von dna-methylierungsbiomarkern und nachweisverfahren dafür sowie kit davon
EP4144859A4 (de) Reagens und kit zum nachweis von tumoren
EP3724352A4 (de) Tragbare vorrichtungen und verfahren zur analyse von proben
EP4092050A4 (de) Verfahren und antikörper zum nachweis von hbcag
EP3908657A4 (de) Verfahren zum nachweis von analyten und zusammensetzungen davon
EP3722811A4 (de) Kit und verfahren zum quantitativen nachweis von hbsag
DK4200018T3 (da) Anti-par-2-antistoffer og fremgangsmåder til anvendelse deraf
EP4153357A4 (de) Vorrichtungen, tests und verfahren zum nachweis von nukleinsäuren
EP4230953C0 (de) Abweichungsdetektionsverfahren und abweichungsdetektionsvorrichtung
EP4517304A4 (de) Blutzellenanalysegerät zum nachweis von archaeozyten und nachweisverfahren
IL311301A (en) Anti-siglec-6 antibodies and methods of use thereof
EP4535194A4 (de) Bestimmungsvorrichtung und bestimmungsverfahren
EP4570923A4 (de) Blasenkrebsdetektionskit und detektionsverfahren
EP4163397A4 (de) Probentransportkit zum nachweis von atemwegspathogenen und verfahren zum nachweis von atemwegspathogenen damit
EP4459281A4 (de) Nachweisverfahren und nachweisreagens
EP3805745A4 (de) Gasdetektionsvorrichtung und gasdetektionsverfahren
EP4237090A4 (de) Verfahren zum nachweis und zur behandlung von ovarialkarzinom
EP4237440A4 (de) Immunoassays mit hohem durchsatz und verfahren zum nachweis von sars-cov-2-antigenen
EP4386385A4 (de) Immuntestverfahren, probenverdünnungsmittel und immunchromatografiekit

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20220331

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

A4 Supplementary search report drawn up and despatched

Effective date: 20250115

RIC1 Information provided on ipc code assigned before grant

Ipc: G01N 33/543 20060101ALI20250109BHEP

Ipc: G01N 33/58 20060101ALI20250109BHEP

Ipc: G01N 33/577 20060101ALI20250109BHEP

Ipc: G01N 33/558 20060101ALI20250109BHEP

Ipc: G01N 33/569 20060101AFI20250109BHEP

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20250805